liraglutide
Showing 26 - 50 of 281
Obesity Trial in Loma Linda (Semaglutide, Orlistat, Phentermine/Topiramate)
Recruiting
- Obesity
- Semaglutide
- +4 more
-
Loma Linda, CaliforniaNovo Nordisk Investigational Site
Jan 24, 2023
Type 2 Diabetes, Peripheral Arterial Disease Trial in Napoli (Liraglutide, Control)
Recruiting
- Type 2 Diabetes
- Peripheral Arterial Disease
- Liraglutide
- Control
-
Napoli, ItalyUnit of Endocrinology and Metabolic Diseases and Unit of Diabete
Jun 9, 2021
In Market Utilisation of Liraglutide Used for Weight Management
Enrolling by invitation
- Obesity
- Overweight
- Liraglutide
-
Soeborg, DenmarkNovo Nordisk Investigational Site
Apr 27, 2021
INSPIRE Turkey :A Research Study Looking at Clinical Parameters
Not yet recruiting
- Obesity
- Liraglutide
-
Istanbul, TurkeyNovo Nordisk Investigational Site
Jun 24, 2022
Obesity Trial in Mansourah, Mansoura (Liraglutide)
Recruiting
- Obesity
- Liraglutide
-
Mansourah, Dakhlia, Egypt
- +1 more
Feb 24, 2022
Diabetes, Type II Trial in Asheville (Liraglutide, Insulin)
Completed
- Diabetes Mellitus, Type II
- Liraglutide
- Insulin
-
Asheville, North CarolinaMountain Diabetes and Endocrine Center
Feb 23, 2021
Type1 Diabetes, Autoimmune Diabetes Trial in Changsha (Liraglutide, UCB-Treg, Insulin)
Recruiting
- Type1 Diabetes Mellitus
- Autoimmune Diabetes
- Liraglutide
- +2 more
-
Changsha, Hunan, ChinaInstitute of Metabolism and Endocrinology, Second Xiangya Hospit
Mar 24, 2021
Diabetes, Type 1 Trial in Hvidovre (Liraglutide, Placebo)
Completed
- Diabetes Mellitus, Type 1
- Liraglutide
- Placebo
-
Hvidovre, Capital, DenmarkDep. of Endocrinology, Hvidovre University Hospital
Mar 28, 2021
Replication of LEAD-2 Diabetes Trial in Healthcare Claims Data
Completed
- Diabetes
- Glimepiride
- Liraglutide
-
Boston, MassachusettsBrigham and Women's Hospital
Dec 16, 2021
Obesity Trial in Worldwide (Liraglutide, Placebo)
Active, not recruiting
- Obesity
- Liraglutide
- Placebo
-
Denver, Colorado
- +25 more
Jun 8, 2022
Glucagon-Like Peptide-1 Receptor, Metformin, Obesity, Abdominal Trial in Shanghai (Liraglutide, Semaglutide, Metformin)
Recruiting
- Glucagon-Like Peptide-1 Receptor
- +7 more
- Liraglutide
- +2 more
-
Shanghai, Shanghai, ChinaRen Ji Hospital, Shanghai Jiao Tong University School of Medicin
Mar 9, 2023
Pulmonary Disease, Chronic Obstructive Trial in Esbjerg, Vejle (Liraglutide, Placebo)
Completed
- Pulmonary Disease, Chronic Obstructive
- Liraglutide
- Placebo
-
Esbjerg, Denmark
- +1 more
Mar 12, 2021
Morbid Obesity, Bariatric Surgery Candidate Trial in Offenbach (drug, other, dietary supplement)
Completed
- Morbid Obesity
- Bariatric Surgery Candidate
- Liraglutide
- +2 more
-
Offenbach, Hessen, GermanySana Klinikum Offenbach
Mar 21, 2021
Type 2 Diabetes Trial in Marseille (Liraglutide, Metformin or sulfonylurea)
Completed
- Type 2 Diabetes
- Liraglutide
- Metformin or sulfonylurea
-
Marseille, FranceNutrition department, pole ENDO - Assistance Publique Hôpitaux M
Jun 14, 2021
Type 1 Diabetes Trial in Uppsala (Liraglutide, Placebo for liraglutide)
Completed
- Type 1 Diabetes
- Liraglutide
- Placebo for liraglutide
-
Uppsala, SwedenUppsala University Hospital
Nov 4, 2020
Diabetes Type 2, Diastolic Dysfunction, Cardiac MRI Trial in Copenhagen Ø (Liraglutide, Placebo)
Completed
- Diabetes Mellitus Type 2
- +3 more
- Liraglutide
- Placebo
-
Copenhagen Ø, DenmarkThe department of cardiology, Rigshospitalet Denmark
Jan 13, 2021
Type 2 Diabetes Trial in Spain (liraglutide, )
Completed
- Type 2 Diabetes
- liraglutide
- placebo
-
Badalona, Barcelona, Spain
- +5 more
Feb 9, 2021
Diabetes Type 2 Trial in Doha (Metformin, Gliclazide, Sitagliptin)
Active, not recruiting
- Diabetes Mellitus Type 2
- Metformin
- +6 more
-
Doha, QatarHamad Medical Corporation
Apr 27, 2022
Obesity Trial in Changsha (Liraglutide, Exenatide, Exenatide Microspheres for Injection)
Recruiting
- Obesity
- Liraglutide
- +2 more
-
Changsha, Hunan, ChinaXiangya Hospital of Central South University
Apr 7, 2021
Type 2 Diabetes, Coronary Artery Disease Trial in Athens (Liraglutide, Metformin)
Completed
- Type 2 Diabetes Mellitus
- Coronary Artery Disease
- Liraglutide
- Metformin
-
Athens, Attiki, Greece''Attikon'' University General Hospital
Mar 3, 2021
Type 2 Diabetes Patients, Overweight and Obesity, Hyperglycaemia (Diabetic) Trial in Xiamen (Liraglutide, insulin glargine)
Unknown status
- Type 2 Diabetes Patients
- +2 more
- Liraglutide
- insulin glargine
-
Xiamen, Fujian, ChinaThe first afilliated hospital of Xiamen university
Aug 4, 2020
Sleep Apnea, Sleep Disordered Breathing Trial in Cincinnati (liraglutide)
Completed
- Sleep Apnea
- Sleep Disordered Breathing
- liraglutide
-
Cincinnati, OhioCincinnati Children's Hospital Medical Center
Sep 26, 2020
Monoclonal Gammopathies, Overweight, Obesity Trial (Liraglutide)
Withdrawn
- Monoclonal Gammopathies
- +2 more
- Liraglutide
- (no location specified)
Sep 17, 2020
Gestational Diabetes Trial in Hellerup (Liraglutide, Placebo)
Completed
- Gestational Diabetes Mellitus
- Liraglutide
- Placebo
-
Hellerup, DenmarkClinical Metabolic Physiology, Steno Diabetes Center Copenhagen
Nov 3, 2020